Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen Sells 4,655 Shares of Stock

Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 4,655 shares of the firm’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total value of $27,324.85. Following the completion of the sale, the chief accounting officer directly owned 146,608 shares of the company’s stock, valued at approximately $860,588.96. This represents a 3.08% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Amir Cohen also recently made the following trade(s):

• On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The stock was sold at an average price of $5.91, for a total value of $239,798.25.
• On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The stock was sold at an average price of $5.79, for a total value of $59,637.00.

Strata Critical Medical Stock Performance

Shares of NASDAQ SRTA opened at $5.48 on Thursday. The firm has a market capitalization of $474.18 million, a P/E ratio of -68.50 and a beta of 2.20. The business has a 50-day simple moving average of $5.17. Strata Critical Medical has a fifty-two week low of $3.57 and a fifty-two week high of $6.50.

Strata Critical Medical (NASDAQ:SRTA) last released its earnings results on Wednesday, May 6th. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.07. Strata Critical Medical had a negative return on equity of 4.06% and a net margin of 20.56%.The firm had revenue of $67.38 million during the quarter. On average, analysts expect that Strata Critical Medical will post -0.14 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on SRTA. Craig Hallum began coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective on the stock. Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Zacks Research upgraded shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. Finally, B. Riley Financial began coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $8.00.

Institutional Trading of Strata Critical Medical

A number of institutional investors and hedge funds have recently made changes to their positions in SRTA. Seelaus Asset Management LLC increased its position in shares of Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after buying an additional 6,000 shares in the last quarter. Granite Investment Partners LLC increased its position in shares of Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after buying an additional 7,911 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in shares of Strata Critical Medical in the first quarter valued at approximately $537,000. Dimensional Fund Advisors LP increased its position in shares of Strata Critical Medical by 11.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after buying an additional 172,154 shares in the last quarter. Finally, Quantinno Capital Management LP increased its position in shares of Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after buying an additional 71,155 shares in the last quarter. 47.36% of the stock is currently owned by hedge funds and other institutional investors.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.